Jan McKendrick

929 citations

26 papers · 640 indexed · h-index 13

Impact in

Periodontics top 5%
- Dental Health and Care Utilization
- Oral microbiology and periodontitis research
Psychiatry and Mental health top 5%
- Schizophrenia research and treatment
- Bipolar Disorder and Treatment

Papers in

Psychiatry and Mental health 10
- Schizophrenia research and treatment 10
- Bipolar Disorder and Treatment 3
Family Practice 1

Co-authors: D. Stephenson Tom Burns Zhiming Li Christopher M. Thompson Robert Peveler Ami Claxton Gavin Young Ruth Filik
Journals: European Neuropsychopharmacology (4 papers)Acta Psychiatrica Scandinavica (3 papers)Advances in Therapy (2 papers)Value in Health (2 papers)Blood (1 paper)
Partner nations: United States United Kingdom Italy

In The Last Decade

Jan McKendrick

26 papers receiving 608 citations

Peers

Countries citing papers authored by Jan McKendrick

Since Specialization

Citations

This map shows the geographic impact of Jan McKendrick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan McKendrick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan McKendrick more than expected).

Fields of papers citing papers by Jan McKendrick

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jan McKendrick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan McKendrick. The network helps show where Jan McKendrick may publish in the future.

Co-authors

The 25 scholars most cited alongside Jan McKendrick, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Jan McKendrick Line = papers co-authored together Jan McKendrick links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Clinicians’ Perspectives on Cure in Adult Patients with Acute Lymphoblastic Leukemia with Minimal Residual Disease: A Delphi Study Advances in Therapy ·Wendy Gidman, Liu Nai-kui, Lirong Zhang, Jan McKendrick, Ze Cong, David Cohan, Oliver G. Ottmann	2019	5
2	Measuring Survival Benefit in Health Technology Assessment in the Presence of Nonproportional Hazards Value in Health ·Lisa K. Carlstrom, G. Gagni, Jan McKendrick, Yun Su	2019	16
3	Clinician Concepts of Cure in Adult Relapsed and Refractory Philadelphia-Negative B Cell Precursor Acute Lymphoblastic Leukemia: A Delphi Study Advances in Therapy ·Renato Bassan, Dieter Hoelzer, Xavier Thomas, Pau Montesinos, Jiří Pavlů, Jan McKendrick, AD Peris, Arie Barlev, Beth Barber, Ze Cong	2019	4
4	Quality-of-Life Outcomes in Patients with Relapsed or Refractory Multiple Myeloma Treated with Elotuzumab Plus Lenalidomide/Dexamethasone or Lenalidomide/Dexamethasone: Final Analysis of the Phase 3 ELOQUENT-2 Study Blood ·David Cella, Jan McKendrick, Huriye Nur KANTAR, Ravi Vij, Clara Chen	2019	1
5	Testing for minimal residual disease in adults with acute lymphoblastic leukemia in Europe: a clinician survey BMC Cancer ·Arnaud Pigneux, Pau Montesinos, Ze Cong, Xinke Zhang, W. MCD, 康史武藤, Jan McKendrick, Monika Brüggemann	2018	11
6	Impact of elotuzumab treatment on pain and health-related quality of life in patients with relapsed or refractory multiple myeloma: results from the ELOQUENT-2 study Annals of Hematology ·David Cella, Jan McKendrick, AD Peris, Antonio Palumbo, Abderrahim Oukessou, Ravi Vij, Teresa Zyczynski, Catherine Davis	2018	14
7	The impact of patient characteristics and disease-specific factors on first-line treatment decisions for BRAF-mutated melanoma: results from a European expert panel study Melanoma Research ·Paolo A. Ascierto, Lars Bastholt, Pier Francesco Ferrucci, Johan Hansson, Iván Márquez‐Rodas, Miranda Payne, Caroline Robert, L. Thomas, Jochen Utikal, Pascal Wolter, AD Peris, Olivier Loubès, Jan McKendrick	2018	9
8	Identification and Management of Statin-Associated Symptoms in Clinical Practice: Extension of a Clinician Survey to 12 Further Countries Cardiovascular Drugs and Therapy ·Robert S. Rosenson, Shravanthi R. Gandra, Jan McKendrick, Ricardo Dent, 康史武藤, Hana fadhil salman, Alberico L. Catapano, Paul Oh, G. Kees Hovingh, Erik S.G. Stroes	2017	15
9	Estimating healthcare resource use associated with the treatment of metastatic melanoma in eight countries Journal of Medical Economics ·Jan McKendrick, Merel Gijsen, Casey Quinn, Beth Barber, Zhongyun Zhao	2016	2
10	Identification and management of patients with statin-associated symptoms in clinical practice: A clinician survey Atherosclerosis ·G. Kees Hovingh, Shravanthi R. Gandra, Jan McKendrick, Ricardo Dent, 康史武藤, Alberico L. Catapano, Paul Oh, Robert S. Rosenson, Erik S.G. Stroes	2015	45
11	Measurement of quality of life in schizophrenia: a comparison of two scales Social Psychiatry and Psychiatric Epidemiology ·Sarah Yelin Lee, Richard Laugharne, Stefan Zander, Jan McKendrick, D. Stephenson, Atefe Khazeni, LI Ti-kang, Louis Rotenberg, Tom Burns	2007	27
12	The impact of intellectual functioning on symptoms and service use in schizophrenia Journal of Intellectual Disability Research ·Robert Chaplin, LI Ti-kang, Stephen Cooper, Sarah Yelin Lee, Jan McKendrick, D. Stephenson, A.M. Micaller, Atefe Khazeni, Theodora Kostakopoulou, Tom Burns	2006	16
13	The cardiovascular and respiratory health of people with schizophrenia Acta Psychiatrica Scandinavica ·Ruth Filik, Attila Sipos, Patrick G. Kehoe, Tom Burns, Stephen Cooper, Helen Stevens, Richard Laugharne, Gavin Young, Stefan Zander, Jan McKendrick, D. Stephenson, Glynn Harrison	2006	111
14	Cost effectiveness of olanzapine in prevention of affective episodes in bipolar disorder in the United Kingdom Journal of Psychopharmacology ·Jan McKendrick, Karin Cerri, Andrew R. Lloyd, ابراهیم یونس وکاع الراوي, Chadaporn Nongkhunsarn, Peerawat Chaisuk	2006	15
15	Maintenance antipsychotic medication patterns in outpatient schizophrenia patients: a naturalistic cohort study Acta Psychiatrica Scandinavica ·Tom Burns, Linlin Wang, Stephen Cooper, Glynn Harrison, Jan McKendrick, Richard Laugharne, A.M. Micaller, Robin G. McCreadie, Sinéad O’Brien, Stefan Zander, D. Stephenson	2005	19
16	The dental health of people with schizophrenia Acta Psychiatrica Scandinavica ·Robin G. McCreadie, Helen Stevens, John Henderson, David J. Hall, Louis Rotenberg, Ruth Filik, Gavin Young, S. Strazzulla, D. Ridgley, Stefan Zander, Jan McKendrick, D. Stephenson, Tom Burns	2004	113
17	Economic evaluation of gemcitabine in the treatment of pancreatic cancer in the UK The European Journal of Health Economics ·Wilfred P. Dvorak, Michael Lees, N. Botwood, Jan McKendrick, D. Stephenson, Nikos Maniadakis	2003	12
18	Selective serotonin reuptake inhibitor treatment in the UK: Risk of relapse or recurrence of depression The British Journal of Psychiatry ·Ami Claxton, Zhiming Li, Jan McKendrick	2000	59
19	Compliance with antidepressant treatment of depression in primary care in the UK European Neuropsychopharmacology ·Jan McKendrick, D. Stephenson, C. Thompson, R.C. Peveler	1998	1
20	Antidepressant prescribing patterns and risk of relapse and recurrence of depression in a primary care cohort in the United Kingdom European Neuropsychopharmacology ·K.J. Bottesi, Ami Claxton, Jan McKendrick	1998	1

About Jan McKendrick

Jan McKendrick is a scholar working on Psychiatry and Mental health, Family Practice, Biological Psychiatry, Behavioral Neuroscience and Philosophy, having authored 26 papers that have together received 640 indexed citations. Recurring topics across this work include Schizophrenia research and treatment (10 papers), Health Systems, Economic Evaluations, Quality of Life (5 papers), Mental Health Treatment and Access (4 papers), Childhood Cancer Survivors' Quality of Life (3 papers), Cardiac Health and Mental Health (3 papers), Bipolar Disorder and Treatment (3 papers), Acute Lymphoblastic Leukemia research (3 papers) and Treatment of Major Depression (3 papers). The work is most often cited by research in Periodontics (79 citations), Psychiatry and Mental health (247 citations), Family Practice (28 citations), Social Psychology (103 citations) and Biological Psychiatry (11 citations). Jan McKendrick has collaborated with scholars based in United States, United Kingdom and Italy. Frequent co-authors include D. Stephenson, Tom Burns, Zhiming Li, Christopher M. Thompson, Robert Peveler, Ami Claxton, Gavin Young, Ruth Filik, Helen Stevens and Richard Laugharne. Their work appears in journals such as European Neuropsychopharmacology, Acta Psychiatrica Scandinavica, Advances in Therapy, Value in Health and Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact